<DOC>
	<DOCNO>NCT01474382</DOCNO>
	<brief_summary>The purpose study determine whether OraVerse safe effective reversal dental anesthesia child 2 5 year age weigh least 10 kg .</brief_summary>
	<brief_title>Study OraVerse® Safety Efficacy Pediatric Dental Patients</brief_title>
	<detailed_description>This Phase 4 clinical study design multicenter , randomize , double-blinded , control study evaluate safety efficacy OraVerse approximately 150 child 2 5 year age . OraVerse sham injection administer completion dental procedure require local anesthesia lidocaine 2 % 1:100,000 epinephrine . The dental procedure ( ) comprising restoration/fillings shall perform single quadrant mouth . The primary endpoint safety tolerability OraVerse measure adverse event , vital sign , oral cavity assessment , nerve injury , analgesic intraoral pain . Secondary objective subject 4 5 year age include safety tolerability OraVerse measure pain assessment use W-B PRS evaluation efficacy assess pediatric Functional Assessment Battery ( pFAB ) standardize lip tongue palpation procedure .</detailed_description>
	<mesh_term>Phentolamine</mesh_term>
	<criteria>Male female , 2 5 year age Sufficiently healthy determine Investigator receive routine dental care Requires restorative procedure ( restoration/filling ) single quadrant mouth Requires local anesthesia lidocaine 2 % 1:100,000 epinephrine administer submucosal injection For subject undergo mandibular procedure , require inferior alveolar nerve block restorative procedure Dental procedure ( ) complete within 60 minute injection local anesthetic For subject 4 5 year age , train standardized lip/tongue palpation procedure pFAB Subjects trainable pFAB standardize lip/tongue palpation procedure either : normal pFAB baseline prior administration local anesthetic least one abnormal function ( smile , speaking , drink drool ) completion dental procedure OR normal lip sensation baseline prior administration local anesthetic numbness relevant lip quadrant completion dental procedure Subjects give write verbal assent , capable appropriate , parent ( ) legal guardian ( ) give write informed consent Weight le 10 kg Weight le 15 kg 4 5 year age History presence condition contraindicate routine dental care use local anesthetic Requires ¼ cartridge local anesthetic weight ≥ 10 kg &lt; 15 kg , ½ cartridge local anesthetic weight ≥ 15 kg &lt; 30 kg , 1 cartridge local anesthetic weight ≥ 30 kg , exclude supplemental injection Allergy intolerance lidocaine , epinephrine , sulfites , phentolamine , nitrous oxide topical benzocaine Has use investigational drug and/or participate clinical study within 30 day study drug administration Has participate study previous study phentolamine mesylate reversal local soft tissue anesthesia ( STA ) Any use commercial OraVerse™ within 30 day study drug administration Use opioid opioidlike analgesic within 24 hour prior administration local anesthetic Requires use local anesthetic lidocaine 2 % 1:100,000 epinephrine perform schedule dental procedure Requires use general anesthesia sedatives except nitrous oxide perform schedule dental procedure Any condition opinion Investigator increase risk subject participate study decrease likelihood compliance protocol</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>OraVerse</keyword>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Reversal dental anesthesia</keyword>
</DOC>